Henry Brem is a Neurosurgery provider in Baltimore, Maryland. Dr. Brem is rated as an Elite provider by MediFind in the treatment of Meningioma. His top areas of expertise are Gliosarcoma, Glioma, Brain Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Osteotomy.

Dr. Jon Weingart focuses on the surgical treatment of brain tumors including benign and malignant tumors. Dr. Weingart also specializes in spinal disorders, such as cervical and lumbar disc disease, as well as other congenital and developmental abnormalities such as tethered spinal cord, spina bifida and chiari malformation. Dr. Weingart is rated as an Elite provider by MediFind in the treatment of Meningioma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Osteotomy.

Dr. Debraj “Raj” Mukherjee’s clinical focus is the treatment of patients with primary and metastatic brain lesions. His clinical work and research emphasize the development of individual treatment plans that optimize survival and quality of life in all patients. After receiving his medical degree from Dartmouth Medical School, Dr. Mukherjee was recruited to Johns Hopkins, where he studied epidemiology, biostatistics and clinical design at the Johns Hopkins Bloomberg School of Public Health and served as Director of the Neuro-Oncology Surgical Outcomes Laboratory in the Department of Neurosurgery. Dr. Mukherjee completed neurosurgery residency at Cedars-Sinai Medical Center, where he was named a Robert Wood Johnson Foundation Health & Society Scholar. He completed an open and endoscopic skull base fellowship with the Center for Skull Base Surgery at University of Pittsburgh Medical Center, where he was a Copeland Scholar. Throughout his career, Dr. Mukherjee has led patient-centered research pursuits in neuro-oncology including development of a national registry for patients with brain tumors, creation of disease-specific quality of life instruments for patients with skull base tumors, and development of innovative clinical trials in neuro-oncology. He leads the Meningioma, Brain Metastasis, and Neurosurgical Oncology centers at Johns Hopkins Medicine, and he serves as Assistant Residency Program Director for one of the largest neurosurgical training programs in the country. His work has been supported by the American Medical Association, Glioblastoma Foundation, National Institute on Aging, and National Cancer Institute. Dr. Mukherjee can be contacted at drraj@jhmi.edu. Dr. Mukherjee is rated as an Elite provider by MediFind in the treatment of Meningioma. His top areas of expertise are Meningioma, Pituitary Tumor, Brain Tumor, Awake Craniotomy, and Laminectomy.

Dr. Gary Gallia's specialty is endoscopic endonasal surgical approaches to skull base pathologies with a focus on neurosurgical oncology. He utilizes the latest techniques in preoperative imaging, computer-guided surgical navigation, intraoperative monitoring, and minimally invasive and Neuroendoscopy approaches in the management of patients with benign and malignant brain tumors, metastatic tumors to the brain, skull base neoplasms, and pituitary tumors. He is the director of the Neurosurgery Skull Base Center and surgical director of the Johns Hopkins Pituitary Center. Dr. Gary Gallia graduated summa cum laude from the Gibbons Scholar MD/PhD program at Jefferson Medical College and Thomas Jefferson University. He completed his general surgery internship at The Johns Hopkins Hospital where he was awarded surgical intern of the year. He then completed his neurological surgery residency and a postdoctoral fellowship in neuro-oncology at The Johns Hopkins Hospital. Following residency, he completed a minimally invasive and endoscopic neurosurgery fellowship with Dr. Charles Teo at the Prince of Wales Private Hospital and Sydney Children's Hospital in Sydney, Australia. Dr. Gallia is rated as a Distinguished provider by MediFind in the treatment of Meningioma. His top areas of expertise are Olfactory Neuroblastoma, Chordoma, Pituitary Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Awake Craniotomy.

Christopher Jackson is a neurosurgeon who specializes in brain tumors and cerebrovascular disorders, including glioma, meningioma, acoustic neuroma, trigeminal neuralgia, brain metastasis, arteriovenous malformation, and aneurysms. He is the director of the Acoustic Neuroma Center. Dr. Jackson earned his medical degree from the Johns Hopkins University School of Medicine, where he also completed his neurosurgical residency. During his residency, Dr. Jackson was honored with multiple distinctions, including the Frank L. Coulson Jr. Award for Clinical Excellence, the Irving J. Sherman Award for Resident Achievement, the Harvey Cushing Hunterian Research Award, and was elected to Alpha Omega Alpha. Dr. Jackson is an active researcher who has published over 35 peer-reviewed articles on brain tumor and cerebrovascular immunology. His laboratory focuses on how brain tumors evade the immune system and become resistant to immunotherapy. Additionally, Dr. Jackson’s laboratory explores the formation of cerebral aneurysms and inflammatory complications of cerebral aneurysm rupture. Dr. Jackson is rated as a Distinguished provider by MediFind in the treatment of Meningioma. His top areas of expertise are Trigeminal Neuralgia, Meningioma, Dysembryoplastic Neuroepithelial Tumors (DNET), Rhizotomy, and Microvascular Decompression.

Dr. Kleinberg specializes in the radiation treatments, including stereotactic radiosurgery, of brain and spinal tumors. Areas of research include both tumors arising in the central nervous system and tumors metastasizing from other locations. He also specializes in the treatment of esophageal tumors and has led national clinical trials in both therapy of brain tumors as well as esophageal cancer. Dr. Kleinberg has been recently named in the US News and World Report list of top 1% of doctors in his specialty. He is the co-chair of the Eastern Cooperative Oncology Group Brain Tumor Working Group, Vice-Chair of the NCI Cooperative Group Steering Committee for Esophageal and Gastric Tumors, and is a member of the NCI Cooperative Group Steering Committee for Gastrointestinal Tumors. He is also on the American College of Radiation Oncology Neurologic Cancer Practice Accreditation Team. Make A Gift. Dr. Kleinberg is rated as a Distinguished provider by MediFind in the treatment of Meningioma. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, Hepato-Pancreato-Biliary Surgery, and Gamma Knife Radiosurgery.

David Kamson is an Oncologist in Baltimore, Maryland. Dr. Kamson is rated as an Advanced provider by MediFind in the treatment of Meningioma. His top areas of expertise are Brain Tumor, Glioblastoma, Gliosarcoma, Metastatic Brain Tumor, and Hormone Replacement Therapy (HRT).

Dr. Kristin Redmond specializes in the treatment of brain tumors and leads the spinal radiosurgery program. She received her undergraduate degree from Princeton University where she graduated magna cum laude with a focus in neuro-psychology. She attended medical school and obtained a Masters in Public Health in health systems management at Tulane University where she was elected to the Alpha Omega Alpha Honor Medical Society as well as the Gold Humanism in Medicine Honor Society. Dr. Redmonds research interest focuses on the development of novel radiation techniques and therapeutic agents to treat brain and spine tumors in order to increase tumor control and overall survival. In addition, she is working to develop innovative approaches to try to limit long term toxicities and minimize neuro-cognitive dysfunction following treatment for tumors of the central nervous system. Dr. Redmond believes in a holistic approach to medicine and feels that the social and psychological components of patient care are equally important to traditional therapies. She works closely with a team of specialists to support patients and families during their cancer journey. Make A Gift. Dr. Redmond is rated as an Advanced provider by MediFind in the treatment of Meningioma. Her top areas of expertise are Chordoma, Brain Tumor, Astrocytoma, and Metastatic Brain Tumor.

Dr. Majid Khan is a Radiologist and Director, Non-Vascular Spine Intervention at Johns Hopkins University hospitals. Dr. Khan graduated from University of Kashmir, India in 1993. He completed his residency in radiology at the Nassau University Medical Center at Stony Brooks University and then completed his fellowship in Neuroradiology at Johns Hopkins University. Dr. Majid is deeply invested in both diagnostic Neuroradiology with particular emphasis on advanced head & neck and spine tumor imaging. His prime interest is doing spine tumor ablations primarily using microwave ablation devices and has performed the most number of such cases in the United States. He has significant expertise in spine cement augmentation procedures like kyphoplasty and vertebroplasty for treatment of compression fractures due to osteoporosis, multiple myeloma and/or other tumor-associated pathological fractures, sacroplasty for the treatment of fractures of the sacrum, epidural steroid injections, facet and transforaminal nerve blocks. He has treated a considerable number of patients with Tarlov and synovial cysts. Dr. Khan is a core member of Johns Hopkins Headaches and CSF Leak Program doing both targeted and non-targeted blood and fibrin glue patches. In addition, Dr. Khan has performed numerous imaging-guided head and neck biopsies with expertise in deep trans-facial biopsies. Dr. Majid has contributed to numerous publications and book chapters and has given regional, national and international talks, as well as presented research at many national meetings. He is a member of the American Society of Neuroradiology, American College of Radiology, American Society of Spine Radiology, North American Spine Society, Radiologic Society of North America, European Society of Radiology. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Meningioma. His top areas of expertise are Cerebrospinal Fluid Leak, Meningocele, Tarlov Cysts, Vertebroplasty, and Bone Graft.

Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the Johns Hopkins Comprehensive Neurofibromatosis Center and director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care. Dr. Blakeley is rated as an Advanced provider by MediFind in the treatment of Meningioma. Her top areas of expertise are Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy.

Dr. Tamargo specializes in the treatment of aneurysms, arteriovenous malformations (AVMs), arteriovenous fistulas (AVFs), and cavernous malformations of the brain and spinal cord in both adults and children. Dr. Tamargo specializes in revascularization procedures for moyamoya disease. For this condition, Dr. Tamargo performs either a microsurgical encephaloduroarteriomyosynangiosis (EDAMS) or a microsurgical extracranial-to-intracranial artery bypass. Dr. Tamargo also specializes in the treatment of acoustic neuromas (vestibular schwannomas). A recipient of numerous honors and awards, some of Dr. Tamargo's most recent accolades include the Neurosurgery Faculty Teaching Award and the Hopkins Richard S. Ross Clinician Scientist Award. Dr. Tamargo is rated as an Advanced provider by MediFind in the treatment of Meningioma. His top areas of expertise are Brain Aneurysm, Subarachnoid Hemorrhage, Acoustic Neuroma, and Schwannoma.

Dr. Haris Sair is Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science, and the Director of the Division of Neuroradiology. His areas of clinical expertise include functional Magnetic Resonance Imaging (fMRI) of the brain. He also has a faculty appointment in the Malone Center for Engineering in Healthcare at The Whiting School of Engineering, Johns Hopkins University, investigating the use of machine learning and artificial intelligence in imaging. He is a founding director of the Radiology Artificial Intelligence Lab (RAIL). He previously served as the President of the American Society of Functional Neuroradiology. Dr. Sair earned his M.D. from Duke University School of Medicine. He completed his Radiology residency at Temple University Medical Center, and fellowship in Neuroradiology at Massachusetts General Hospital in Boston, MA. Dr. Sair is rated as an Advanced provider by MediFind in the treatment of Meningioma. His top areas of expertise are Hydrocephalus, Normal Pressure Hydrocephalus, Traumatic Brain Injury, Cerebrospinal Fluid Leak, and Microvascular Decompression.

Dr. Watkins received a bachelor of arts degree in Psychobiology from Harvard University and a medical doctor degree from the University of Chicago-Pritzker School of Medicine. She completed internship at Georgetown-INOVA Fairfax Hospital followed by a Diagnostic Radiology residency and Neuroradiology fellowship at Johns Hopkins Hospital. Prior to joining Johns Hopkins, Dr. Watkins was a staff Neuroradiologist for Johns Hopkins Howard County Medical Center and the director of the Bethesda outpatient center for American Radiology from 2006-2015. She then served as Sub Chief of Neuroradiology Mid Atlantic Permanente Medical Group from 2015-2016. Dr. Watkins has served as a Neuroradiology course lecturer for the American College of Radiology, case review lecturer for the Radiological Society of North America and a reviewer for the Neuroradiology section of the Radiographics Journal. Dr. Watkins is rated as an Advanced provider by MediFind in the treatment of Meningioma. Her top areas of expertise are Stroke, Subarachnoid Hemorrhage, Meningioma, and Craniopharyngioma.

Dr. Jenny Hoang is a Professor of Radiology at Johns Hopkins Medicine where she is the Chair of Bayview Radiology. Dr. Hoang earned her M.B.B.S. from the University of Melbourne, completed diagnostic radiology residency at St. Vincent’s Hospital in Melbourne, Australia, and completed fellowships in neuroradiology and cardiothoracic radiology at Duke University Medical Center. Dr. Hoang is a lifelong learner - she graduated with a Masters in Health Science from Duke University. In December 2019 she completed an executive MBA class at the Duke Fuqua School of Business and graduated in the top 10% of her class (Fuqua Scholar). Her career is accentuated by her strong involvement in research and education. She has published more than 110 peer-reviewed articles with a focus on thyroid and parathyroid imaging. She led the American College of Radiology (ACR) efforts in producing a White Paper on Incidental Thyroid Findings and was a core member of the ACR TI-RADS committee for thyroid ultrasound. She serves on several ACR committees including the Incidental Findings Committee. Dr. Hoang is the principal investigator for an ACRIN funded study using ACR's Multicenter Thyroid Ultrasound Registry. She is a popular a faculty lecturer at national and international meetings. She is also well known for actively educating and advocating on Twitter as @JennyKHoang. LinkedIn https://www.linkedin.com/in/JKHoang. Dr. Hoang is rated as an Advanced provider by MediFind in the treatment of Meningioma. Her top areas of expertise are Hydrocephalus, Meningioma, Normal Pressure Hydrocephalus, and Congenital Cardiovascular Shunt.

Dr. Michael Kraut is a Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. Dr. Kraut received his undergraduate degree in B.S. in biomedical engineering from the University of Southern California, and M.D., M.S. and Ph.D. degrees in neuroscience from the Albert Einstein College of Medicine. After a residency in diagnostic radiology at Beth Israel Hospital in Boston, MA, he completed a fellowship in neuroradiology at The Johns Hopkins Hospital, and joined the Johns Hopkins faculty thereafter. Dr. Kraut’s research interests include functional neuroimaging, especially as a tool to investigate cognitive operations and issues of visual and somatomotor function. A special interest, reflecting his background in neurophysiology, is the use of functional imaging techniques in concert with electrophysiologic measures in order to elucidate the temporal sequence as well as spatial distribution of neural activation. In addition to his roles at Johns Hopkins, Dr. Kraut serves as the Medical Director at F.M. Kirby Research Center for Functional Brain Imaging. Dr. Kraut is rated as an Advanced provider by MediFind in the treatment of Meningioma. His top areas of expertise are Pediatric Low-Grade Glioma (pLGG), Meningioma, Subarachnoid Hemorrhage, and Malignant Peripheral Nerve Sheath Tumor.

Robert Hong is a Radiologist and a Radiation Oncologist in Baltimore, Maryland. Dr. Hong is rated as a Distinguished provider by MediFind in the treatment of Meningioma. His top areas of expertise are Posterior Fossa Tumor, Familial Prostate Cancer, Angiosarcoma, and Meningioma. Dr. Hong is currently accepting new patients.

William Regine is a Radiation Oncologist in Baltimore, Maryland. Dr. Regine is rated as an Experienced provider by MediFind in the treatment of Meningioma. His top areas of expertise are Pancreatic Cancer, Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, and Anal Cancer.

Howard Eisenberg is a Neurosurgery provider in Baltimore, Maryland. Dr. Eisenberg is rated as a Distinguished provider by MediFind in the treatment of Meningioma. His top areas of expertise are Essential Tremor, Meningioma, Acoustic Neuroma, Thalamotomy, and Deep Brain Stimulation. Dr. Eisenberg is currently accepting new patients.

Mark Mishra is a Radiation Oncologist in Baltimore, Maryland. Dr. Mishra is rated as a Distinguished provider by MediFind in the treatment of Meningioma. His top areas of expertise are Metastatic Brain Tumor, Astrocytoma, Brain Tumor, Meningioma, and Prostatectomy. Dr. Mishra is currently accepting new patients.

Enslin Aldrich is a Neurosurgery provider in Baltimore, Maryland. Dr. Aldrich is rated as a Distinguished provider by MediFind in the treatment of Meningioma. His top areas of expertise are Meningioma, Apoplexy, Stroke, Gastrostomy, and Awake Craniotomy.